Chargement en cours...

Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment

OBJECTIVE: To investigate the efficacy and safety of the treatment of the newly diagnosed multiple myeloma (MM) with or without renal impairment receiving the therapy of bortezomib, dexamethasone plus thalidomide (BTD) regimen in order to analyze the effects of BTD regimen on the prognosis of the MM...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yang, Guangzhong, Chen, Wenming, Wu, Yin
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3626991/
https://ncbi.nlm.nih.gov/pubmed/23592895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2013.03.07
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!